| |
| |
| Day 1, Wednesday, 03 May 2006 |
 |
| |
|
|
Introduction |
|
|
|
|
| 8:30 a.m. |
Richard Horton, Editor, The Lancet |
| |
|
| 8:45 a.m. |
Mr Khaw Boon Wan, Singapore Minister for Health |
| |
|
| |
Overview |
|
|
|
|
| Chair: |
Dr Richard Horton, London, UK |
| |
|
| 9:00 a.m. |
Overview Of Human Influenza Worldwide |
| |
Professor John Oxford, Scientific Director of Retroscreen Virology Ltd and Professor of Virology at St Bartholomew’s and the Royal London Hospital, Queen Mary’s School of Medicine and Dentistry, London, UK |
| |
|
| 9:25 a.m. |
Overview Of Avian Influenza Worldwide |
| |
Dr Thijs Kuiken, Institute of Virology, Erasmus University, Rotterdam, Netherlands |
| |
|
| 9:50 a.m. |
Lessons From Recent Emerging Infectious Diseases |
| |
Professor Leo Yee Sin, Clinical Director, Communicable Disease Centre, Singapore |
| |
|
| 10:15 a.m. |
Q&A session |
| |
|
| 10:30 a.m. |
Tea break |
| |
|
| |
The Influenza A Virus |
|
|
|
|
|
| Chair: |
Professor John Oxford, London, UK |
| |
|
| 11:00 a.m. |
Antigenic Shift And Drift - Evolution of Avian Influenza Virus |
| |
Dr Yi Guan, Department of Microbiology, University of Hong Kong, Hong Kong SAR, China |
| |
|
| 11:25 a.m. |
Host Range and Interspecies Transmission of Influenza Viruses: Is H5N1 virus alone as a pandemic strain candidate? |
| |
Professor Hiroshi Kida, Department of Diseases Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan |
| |
|
| 11:50 a.m. |
Q&A session |
| |
|
| |
The Avian Dimension |
|
|
|
|
|
| Chair: |
Dr Thijs Kuiken, Rotterdam, Netherlands (invited) |
| |
|
| 12:00 p.m. |
Ecology and Surveillance Of Influenza In Birds |
| |
Professor Kennedy Shortridge, Emeritus Professor, University of Hong Kong, Hong Kong SAR, China |
| |
|
| 12:25 p.m. |
Lessons Learnt from the Dutch H7N7 Avian Influenza Outbreak |
| |
Dr Ron A M Fouchier, WHO National Influenza Centre, Institute of Virology, Erasmus University, Rotterdam, Netherlands |
| |
|
| 12:50 p.m. |
Q&A session |
| |
|
| 1:00 p.m. |
Lunch break |
| |
|
| 1:30 p.m. |
 |
| |
|
| |
Introduction by Chair Speaker |
| |
Dr Lance Jennings, Asia Pacific Advisory Committee on Influenza and Clinical Virologist, Canterbury Health Laboratories, Christchurch, New Zealand |
| |
|
| 1:35 p.m. |
Human H5N1 Disease |
| |
Professor Malik Peiris, Professor of Microbiology, University of Hong Kong, Hong Kong SAR, China |
| |
|
| 1:50 p.m. |
Effectiveness of Oseltamivir in Animal Models of H5N1 Infection |
| |
Dr Elena Govorkova, Division of Virology, Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, USA |
| |
|
| 2:05 p.m. |
Are We Ready? Audit of Government Pandemic Preparedness |
| |
Dr Richard Coker, London School of Hygiene & Tropical Medicine, London, UK |
| |
|
| 2:20 p.m. |
Roche Response to Meeting Pandemic Need |
| |
Dr David Reddy, Tamiflu Task Force Leader, F Hoffmann-La Roche Ltd, Basel, Switzerland |
| |
|
| 2:35 p.m. |
Round Table Discussion |
| |
All |
| |
|
| 2:55 p.m. |
Conclusions |
| |
Dr Lance Jennings, Asia Pacific Advisory Committee on Influenza and Clinical Virologist, Canterbury Health Laboratories, Christchurch, New Zealand |
| |
|
| |
Avian Influenza In Human Beings |
|
|
|
|
|
| Chair: |
Professor Leo Yee Sin, Singapore |
| |
|
| 3:00 p.m. |
Epidemiology and Clinical Manifestations |
| |
Dr Nguyen Tran Hien, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam |
| |
|
| 3:25 p.m. |
Pathogenesis |
| |
Professor Malik Peiris, Professor of Microbiology, University of Hong Kong SAR, China |
| |
|
| 3:50 p.m. |
Q&A session |
| |
|
| 4:00 p.m. |
Tea break |
| |
|
| |
Vaccines |
|
|
|
|
| Chair: |
Professor Kennedy Shortridge, Hong Kong SAR, China |
| |
|
| 4:30 p.m. |
Vaccine Trials |
| |
Dr James D Campbell, University of Maryland Center for Vaccine Development, Baltimore, MD, USA |
| |
|
| 4:55 p.m. |
Development of vaccines against pandemic influenza - the GSK Experience |
| |
Dr Martine Denis, GlaxoSmithKline Biologicals, Rixensart, Belgium |
| |
|
| 5:20 p.m. |
Development of vaccines against pandemic influenza - the Sanofi Pasteur experience |
| |
Dr Melanie Saville, Flu Franchise Leader, Clinical Development, Sanofi Pasteur, Lyon, France |
| |
|
| 5:45 p.m. |
Q&A session |
| |
|
| 6:00 p.m. |
End of Day One |
| |
|
| Day 2, Thursday, 04 May 2006 |
|
| |
|
| |
Antiviral Drugs |
|
|
|
|
| Chair: |
Dr Robert Webster, Memphis, TN, USA |
| |
|
| 9:00 a.m. |
Antiviral Drug Options |
| |
Dr Frederick G Hayden, Professor of Internal Medicine and Pathology, Division of Infectious Diseases, University of Virginia Health Sciences Center, Charlottesville, VA, USA |
| |
|
| 9:25 a.m. |
Building Drug Stockpiles |
| |
Dr David Reddy, Tamiffu Task Force Leader, F Hoffman-La Roche Ltd, Basel, Switzerland |
| |
|
| 9:50 a.m. |
Q&A session |
| |
|
| |
Pandemic Preparedness |
|
|
|
|
|
| Chair: |
Dr Malik Peiris, Hong Kong SAR, China |
| |
|
| 10:00 a.m. |
WHO Pandemic Preparedness Planning |
| |
Dr Jai P Narain, Communicable Diseases, WHO Regional Office for South-East Asia, New Delhi, India
|
| |
|
| 10:25 a.m. |
Q&A session |
| |
|
| 10:30 a.m. |
Tea break |
| |
|
| 11:00 a.m. |
Modelling The Next Pandemic |
| |
Professor Roy M Anderson, Professor of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College, London, UK |
| |
|
| 11:25 a.m. |
Economic Impact Of An Influenza Pandemic |
| |
Dr Martin Meltzer, Senior Health Economist, National Center for Infectious Diseases, Center for Disease Control and Prevention, Atlanta, GA, USA |
| |
|
| 11:50 a.m. |
Pandemic Surveillance And Laboratory Issues |
| |
Dr Lance Jennings, Clinical Virologist, Canterbury Health Laboratories, Christchurch, New Zealand |
| |
|
| 12:15 p.m. |
Q&A session |
| |
|
| 12:30 p.m. |
Lunch break |
| |
|
| Chair: |
Mr John McConnell, London, UK |
| |
|
| 2:15 p.m. |
Implications For Medical Care |
| |
Dr Paul Tambyah, Associate Professor of Medicine and Consultant Infectious Disease Physician, Department of Medicine, National University of Singapore, Singapore |
| |
|
| 2:40 p.m. |
Non-pharmaceutical Options For Control Of Pandemic Influenza |
| |
Dr David M Bell, Senior Adviser for Influenza, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| |
|
| 3:05 p.m. |
Communication – To The Public And Between Nations |
| |
Dr Jane Leese, Senior Medical Officer, Communicable Diseases Branch, Department of Health,
London, UK |
| |
|
| 3:15 p.m. |
Q&A session |
| |
|
| 3:30 p.m. |
Tea break |
| |
|
| |
Case Study |
|
|
|
|
|
| Chair: |
Dr Paul Tambyah, Singapore |
| |
|
| 4:00 p.m. |
What Happened When The H5N1 Virus Visited Thailand |
| |
Dr Kumnuan Ungchusak, Director of Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand |
| |
|
| 4:25 p.m. |
Q&A session |
| |
|
| |
Concluding Remarks |
|
|
|
|
|
| Chair: |
Professor Roy M Anderson, London, UK |
| |
|
| 4:30 p.m. |
Identifying The Gaps In Pandemic Preparation |
| |
Dr Robert G Webster, Rose Marie Thomas Chair, Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA |
| |
|
| 5:00 p.m. |
End Of Forum |
|
|
|
|
|
| |
|
